Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2005-03-29
2005-03-29
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S428000, C514S002600, C514S021800
Reexamination Certificate
active
06872404
ABSTRACT:
The present invention provides a method of reducing intraocular fibrin comprising the administration of a pharmacologically effective dose of Protein C to an individual having elevated levels of intraocular fibrin. Also provided are various methods of preventing intraocular fibrin formation, treating intraocular diseases and reducing intraocular inflammation.
REFERENCES:
patent: 4240163 (1980-12-01), Galin
patent: 4849403 (1989-07-01), Stocker
patent: 5147638 (1992-09-01), Esmon
patent: 5151268 (1992-09-01), Bang
Iverson Arch. Opthalmol. 109, Mar. 1991 p 405.*
Snyder, et al.,Intraocular Fibrinolysis with Recombinant Human Tissue Plasminogen Activator, Arch Ophthalmol, vol. 105, pp. 1277-1280 (1997).
Howard, et al.Intraocular Tissue Plasminogen Activator in a Rabbit Model of Traumatic Hyphema. Arch Ophthalmol, vol. 109, pp. 272-274 (1991).
Brown Harry H.
Fink Louis M.
Marlar Richard A.
Reis Ivory A.
Steinemann Thomas L.
Adler Benjamin Aaron
Kishore Gollamudi S.
University of Arkansas
LandOfFree
Ophthalmologic uses of protein C does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmologic uses of protein C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmologic uses of protein C will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3438380